Treatment of Cardiovascular Diseases - G20

  • G20
  • In 2025, the projected revenue in the Treatment of Cardiovascular Diseases market is set to reach a staggering US$0.41tn.
  • Looking ahead, the market is expected to display a steady annual growth rate (CAGR 2025-2029) of 4.02%.
  • This growth trajectory will ultimately lead to a market volume of US$0.48tn by 2029.
  • When comparing this data on a global scale, it becomes evident that United States will generate the highest revenue in this market.
  • Specifically, in 2025, United States is expected to generate an impressive revenue of US$140.40bn.
  • This substantiates the significant role United States plays in the Treatment of Cardiovascular Diseases market, both within the G20 and on a global level.
  • In the United States, there is a growing trend towards personalized medicine in the treatment of cardiovascular diseases.

Key regions: Germany, France, Japan, Europe, India

Market
Region
Region comparison
Currency

Revenue

Please wait

Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.

Most recent update: Apr 2024

Source: Statista Market Insights

Please wait

Most recent update: Apr 2024

Source: Statista Market Insights

Health

Access more Market Insights on health topics with our featured report

This report presents a comprehensive analysis and additional information on the Treatment of Cardiovascular Diseases market, in a PDF format.
Obesity worldwide - Background Obesity worldwide - Cover

Global Comparison

Please wait

Most recent update: Apr 2024

Source: Statista Market Insights

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Key Market Indicators

The following Key Market Indicators give an overview of the social and economic outlook of the selected region and provide additional insights into relevant market-specific developments. These indicators, together with data from statistical offices, trade associations and companies serve as the foundation for the Statista market models.

Please wait

Source: Please wait

Explore more high-quality data on related topic

Discover additional markets

Explore new markets and gain valuable insights into various topics with our Market Insights search function.

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)